Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Cancer Medicine|June 9, 2016
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapyKjetil Boye, Havjin Jacob, Kari-Anne M Frikstad, et al.
Clinical & Experimental Metastasis|September 10, 2015
Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomesEivind Valen Egeland, Kjetil Boye, Solveig J Pettersen, et al.
Marine Drugs|December 22, 2022
Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug DeliveryKarianne Giller Fleten, Astrid Hyldbakk, Caroline Einen, et al.
Journal for Immunotherapy of Cancer|October 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritoneiKjersti Flatmark, Annette Torgunrud, Karianne G Fleten, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survivalKine Mari Bakke, Knut Håkon Hole, Svein Dueland, et al.
Annals of Surgery|August 26, 2024
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal CancerVegar Johansen Dagenborg, Kristoffer Watten Brudvik, Christin Lund-Andersen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serumKjersti Flatmark, Gunhild M Maelandsmo, Svein-Ole Mikalsen, et al.
The Journal of Pathology|August 5, 2003
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancerKjersti Flatmark, Kjetil Boye Pedersen, Jahn M Nesland, et al.
Pleura and Peritoneum|April 6, 2023
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritoneiThale D J H Patrick-Brown, Faheez Mohamed, Andrew Thrower, et al.
Scientific Reports|March 25, 2021
Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancerKarianne Giller Fleten, J Johannes Eksteen, Brynjar Mauseth, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Cancer Medicine|June 9, 2016
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapyKjetil Boye, Havjin Jacob, Kari-Anne M Frikstad, et al.
Clinical & Experimental Metastasis|September 10, 2015
Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomesEivind Valen Egeland, Kjetil Boye, Solveig J Pettersen, et al.
Marine Drugs|December 22, 2022
Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug DeliveryKarianne Giller Fleten, Astrid Hyldbakk, Caroline Einen, et al.
Journal for Immunotherapy of Cancer|October 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritoneiKjersti Flatmark, Annette Torgunrud, Karianne G Fleten, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survivalKine Mari Bakke, Knut Håkon Hole, Svein Dueland, et al.
Annals of Surgery|August 26, 2024
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal CancerVegar Johansen Dagenborg, Kristoffer Watten Brudvik, Christin Lund-Andersen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serumKjersti Flatmark, Gunhild M Maelandsmo, Svein-Ole Mikalsen, et al.
The Journal of Pathology|August 5, 2003
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancerKjersti Flatmark, Kjetil Boye Pedersen, Jahn M Nesland, et al.
Pleura and Peritoneum|April 6, 2023
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritoneiThale D J H Patrick-Brown, Faheez Mohamed, Andrew Thrower, et al.
Scientific Reports|March 25, 2021
Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancerKarianne Giller Fleten, J Johannes Eksteen, Brynjar Mauseth, et al.
Pageof 14